Medacta Group S.A.
MEDGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,420 | $1,616 | $1,563 | $1,520 |
| - Cash | $33 | $32 | $16 | $21 |
| + Debt | $255 | $241 | $231 | $202 |
| Enterprise Value | $1,642 | $1,825 | $1,778 | $1,701 |
| Revenue | $344 | $302 | $289 | $256 |
| % Growth | 14% | 4.6% | 12.9% | – |
| Gross Profit | $235 | $202 | $198 | $172 |
| % Margin | 68.3% | 66.8% | 68.5% | 67.3% |
| EBITDA | $97 | $65 | $78 | $48 |
| % Margin | 28.2% | 21.4% | 26.9% | 18.9% |
| Net Income | $60 | $35 | $38 | $18 |
| % Margin | 17.4% | 11.6% | 13.2% | 7.1% |
| EPS Diluted | 3.01 | 1.76 | 1.9 | 0.91 |
| % Growth | 71% | -7.4% | 108.8% | – |
| Operating Cash Flow | $73 | $65 | $42 | $38 |
| Capital Expenditures | -$56 | -$40 | -$49 | -$32 |
| Free Cash Flow | $17 | $25 | -$7 | $5 |